RedTram News Search Engine
Русский  English Українська  Français  Polski  Deutsch  Italiano  Español  中文   
21 October 2009 year (time zone GMT 00:00)  Number of sources in English: 4957
Navigating the themes
Navigating the regions
All Themes Health & Beauty Pharmaceutics World
Pharmaceutics (World) RSS 2.0

P&G Touts Green Practices

21.10.2009 17:07    brandweek.com
New report shows waste disposal, CO2 reductions of more than 50 percent.
P&G Touts Green Practices


Nanoxis to Attend 3rd Annual Proteomics Europe Conference and Exhibition

21.10.2009 16:46    drugdevelopment-technology.com
Nanoxis will attend the 3rd Annual Proteomics Europe conference and exhibition in Barcelona, which will be held 5-6 November 2009. This conference and exhibition is co-located with Advances in Metabolic Profiling, Mass Spec Europe and the European Biomarkers Summit.For more
World    Pharmaceutics    Press-releases
Nanoxis to Attend 3rd Annual Proteomics Europe Conference and Exhibition

The Latest News from FOCUS Clinical Drug Development

21.10.2009 16:45    drugdevelopment-technology.com
We would like to inform our sponsors about our new capabilities and latest accomplishments:The recent FDA pre-approval inspection audit of our Phase II clinical study site and office facilities in Moscow, Russia, was flawless and resulted in no FDA 483
World    Pharmaceutics    Press-releases
The Latest News from FOCUS Clinical Drug Development

New Coupling Agents from Bachem

21.10.2009 16:45    drugdevelopment-technology.com
The coupling reaction is the critical step in peptide synthesis. In particular, the solid-phase approach relies on rapid peptide bond formation and complete conversion with a minimum of concomitant side-reactions such as racemization. To meet these requirements a plethora of
World    Pharmaceutics    Press-releases
New Coupling Agents from Bachem


Sygnature Chemical Services and Heptares Therapeutics Announce Contract Chemistry Collaboration

21.10.2009 16:45    drugdevelopment-technology.com
Sygnature Chemical Services, a leading provider of premium medicinal chemistry and computational chemistry services to the global pharmaceutical industry, and Heptares Therapeutics, a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), have announced that they have
World    Pharmaceutics    Press-releases
Sygnature Chemical Services and Heptares Therapeutics Announce Contract Chemistry Collaboration

Almac Expansion Expected to Create 500 Jobs Over the Next Five Years

21.10.2009 16:45    drugdevelopment-technology.com
Almac, one of Northern Ireland's leading businesses, has secured planning permission for major expansion plans that could potentially see the company create over 500 jobs during the next five years. The global company, which provides integrated research, development and manufacturing
World    Pharmaceutics    Press-releases
Almac Expansion Expected to Create 500 Jobs Over the Next Five Years

1